Pharmacy
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Pharmacy
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages

The Best of 2009
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all

Articles: Major Studies



Latest () Month's Top Read Top 50 of Year  
Receive free subspecialty "5-minute updates" via email
Impact study showed longer valcyte (valganciclovir hydrochloride tablets) treatment demonstrated better protection against cytomegalovirus (cmv) disease one year post-transplant
Roche, 06/04/09    Free full text
Sponsor
Cytokinetics Presents Clinical Data Relating To Ispinesib in Patients with Metastatic Breast Cancer at the 2009 Annual Meeting of the American Society of Clinical Oncology
Cytokinetics, 06/03/09    Free full text
GSKs Pazopanib significantly delayed tumor progression in patients with advanced kidney cancer
GlaxoSmithKline, 06/02/09    Free full text
Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week
Salix Pharmaceuticals, 06/02/09    Free full text
Phase III study data with vandetanib (ZACTIMA) in patients with advanced non-small cell lung cancer (NSCLC) presented at American Society of Clinical Oncology
AstraZeneca, 06/01/09    Free full text
Results from Three Phase 2 Studies Reported a Two-Year Survival Rate Ranging from 30 to 42 Percent in Metastatic Melanoma Patients Treated with Ipilimumab
Bristol Myers-Squibb Company, 06/01/09    Free full text
Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
Forest Laboratories, 06/01/09    Free full text
Additional data confirm clopidogrel-PPI interaction
American Pharmacists Association, 05/29/09    Free full text
New Analyses from 16-Year Follow-up Trial with Betaseron Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
Bayer HealthCare Pharmaceuticals, 05/29/09    Free full text
The characterization and comparison of spray-dried mannitol samples
Drug Development and Industrial Pharmacy, 05/29/09
Over 50 years of trial in Acta Psychiatrica Scandinavica: a survey
Trials, 05/29/09    Free full text
New Data Demonstrate RISPERDAL CONSTA (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia
Janssen, 05/28/09    Free full text
New Survey Highlights Growing Concern About Risk of Infection and Emerging Antibiotic Resistance in Cancer Patients
Amgen, 05/28/09    Free full text
Mobile diabetes intervention study: Testing a personalized treatment/behavioral communication intervention for blood glucose control
Contemporary Clinical Trials, 05/27/09
New Study Evaluating the ADHD Medication VYVANSE (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor
Shire, 05/27/09
Two-year data reinforce effectiveness of ACTEMRA in inhibiting joint damage and improving physical function in patients with rheumatoid arthritis
Roche, 05/26/09    Free full text
Phase III data show Novartis investigational bronchodilator QAB149 significantly improves lung function over current treatments in COPD
Novartis, 05/22/09    Free full text
Regulatory and Study Conditions for the Determination of Bioequivalence of Highly Variable Drugs
Journal of Pharmacy and Pharmaceutical Sciences, 05/21/09    Free full text
Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint
Genzyme, 05/21/09    Free full text
Development of an inhibitory antibody fragment to human tissue factor using phage display technology
Drug Development Research, 05/20/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
172 Available Pages
First    Prev    9      10      11      12      13      14      15      16      17      18      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.